Related Experiment Video
Updated: Dec 12, 2025

Author Spotlight: A Model to Study the Systemic and Local Dynamics of CD8+ T Cells During LN Metastasis
Published on: January 26, 2024
Lymph nodes-The neglected battlefield in tuberculosis.
Sharie Keanne C Ganchua1, Alexander G White1, Edwin C Klein2
1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America.
Thoracic lymph nodes are common sites for extrapulmonary tuberculosis (TB) but are understudied. Research highlights their role in TB persistence, vaccine efficacy, and poor drug penetration, necessitating their inclusion in future TB studies.
Area of Science:
- Immunology
- Infectious Diseases
- Microbiology
Background:
- Thoracic lymph nodes are frequent sites of extrapulmonary tuberculosis (TB).
- Mycobacterium tuberculosis (Mtb) infection in lymph nodes remains understudied.
- Lymph nodes are crucial for adaptive immunity and serve as Mtb reservoirs.
Purpose of the Study:
- To highlight the understudied role of thoracic lymph nodes in TB pathogenesis.
- To emphasize the importance of lymph nodes in Mtb persistence and dissemination.
- To advocate for the inclusion of thoracic lymph nodes in TB vaccine and drug efficacy evaluations.
Main Methods:
- Review of existing literature on TB lymph node involvement.
- Analysis of Mtb's interaction with lymph node architecture.
- Comparison of drug and vaccine efficacy in preclinical models focusing on lymph nodes.
Main Results:
- Mtb infection disrupts lymph node architecture, impairing immune function.
- Successful TB vaccines may prevent Mtb spread to lymph nodes.
- Latent TB reactivation can originate in lymph nodes, leading to dissemination.
- Bacille Calmette-Guerin (BCG) vaccine efficacy might be enhanced by lymph node involvement.
- Drug penetration into lymph nodes is significantly poorer than into lung tissues or granulomas.
Conclusions:
- Thoracic lymph nodes are critical, yet overlooked, sites in TB infection and latency.
- Future TB vaccine and drug development must consider lymph node pharmacokinetics and pharmacodynamics.
- Evaluating TB interventions solely based on pulmonary outcomes may underestimate treatment efficacy.
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Secondary Lymphoid Organs
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
Detailed Structure and Function of Lymph Nodes
From a histological perspective, lymph nodes can be split into two main areas: the superficial cortex and the deep medulla. The outer cortex is populated by dendritic cells, macrophages, and B lymphocytes, which are densely packed into follicles. When these B-lymphocytes are presented...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

